{"DataElement":{"publicId":"6930960","version":"1","preferredName":"Organ Standard Toxicity Grade 4 Occurrence Toxicity Type","preferredDefinition":"A description of the organ standard toxicity grade 4 toxicity that occurred.","longName":"5218371v1.0:6941743v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5218371","version":"1","preferredName":"Organ Standard Toxicity Grade 4 Occurrence","preferredDefinition":"A unique macroscopic (gross) anatomic structure that performs specific functions.  It is composed of various tissues.  An organ is part of an anatomic system or a body region.  Representative examples include the heart, lung, liver, spleen, and uterus._Any adverse event that places the patient, in the view of the initial reporter, at immediate risk of death from the adverse event as it occurred, i.e., it does not include an adverse experience that, had it occurred in a more severe form, might have caused death._An instance of something happening, such as an event or incident.","longName":"5218369v1.0:2234856v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5218369","version":"1","preferredName":"Organ Life Threatening or Disabling Adverse Event","preferredDefinition":"A unique macroscopic (gross) anatomic structure that performs specific functions.  It is composed of various tissues.  An organ is part of an anatomic system or a body region.  Representative examples include the heart, lung, liver, spleen, and uterus.:Any adverse event that places the patient, in the view of the initial reporter, at immediate risk of death from the adverse event as it occurred, i.e., it does not include an adverse experience that, had it occurred in a more severe form, might have caused death.","longName":"C13018:C41337","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Organ","conceptCode":"C13018","definition":"A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues.  An organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Life Threatening or Disabling Adverse Event","conceptCode":"C41337","definition":"Any adverse event that places the patient, in the view of the initial reporter, at immediate risk of death from the adverse event as it occurred, i.e., it does not include an adverse experience that, had it occurred in a more severe form, might have caused death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"304F7E5D-9686-63E4-E050-BB89AD436EAB","latestVersionIndicator":"Yes","beginDate":"2016-04-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-04-12","modifiedBy":"ONEDATA","dateModified":"2016-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2234856","version":"1","preferredName":"Occurrence","preferredDefinition":"Occurrence; an instance of something happening.","longName":"C25275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Occurrence","conceptCode":"C25275","definition":"An instance of something happening, such as an event or incident.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-72B8-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"304F7E5D-9694-63E4-E050-BB89AD436EAB","latestVersionIndicator":"Yes","beginDate":"2016-04-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-04-12","modifiedBy":"NYCHM","dateModified":"2016-07-25","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6941743","version":"1","preferredName":"Common Terminology Criteria for Adverse Events Toxicity Type","preferredDefinition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event._The finding of bodily harm due to the poisonous effects of something._Something distinguishable as an identifiable class based on common qualities.","longName":"6941743v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Hepatitis","valueDescription":"Hepatitis viral","ValueMeaning":{"publicId":"6061443","version":"1","preferredName":"Hepatitis viral","longName":"6061443","preferredDefinition":"A disorder characterized by a viral pathologic process involving the liver parenchyma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis Viral, CTCAE","conceptCode":"C143543","definition":"A disorder characterized by a viral pathologic process involving the liver parenchyma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647F72DE-DF8D-0439-E053-F662850A9369","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"HARTLEYG","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C2D813-3FD4-084B-E053-F662850AB4D3","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Cystitis noninfective","valueDescription":"Cystitis noninfective","ValueMeaning":{"publicId":"6061835","version":"1","preferredName":"Cystitis noninfective","longName":"6061835","preferredDefinition":"A disorder characterized by inflammation of the bladder which is not caused by an infection of the urinary tract.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cystitis Noninfective, CTCAE","conceptCode":"C143393","definition":"A disorder characterized by inflammation of the bladder which is not caused by an infection of the urinary tract.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"648E578C-D091-0457-E053-F662850A29EC","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-06","modifiedBy":"HARTLEYG","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C2D813-3FDE-084B-E053-F662850AB4D3","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Chronic kidney disease","valueDescription":"Chronic kidney disease","ValueMeaning":{"publicId":"6061836","version":"1","preferredName":"Chronic kidney disease","longName":"6061836","preferredDefinition":"A disorder characterized by gradual and usually permanent loss of kidney function resulting in renal failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Kidney Disease, CTCAE","conceptCode":"C143369","definition":"A disorder characterized by gradual and usually permanent loss of kidney function resulting in renal failure.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"648E578C-D0B4-0457-E053-F662850A29EC","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-06","modifiedBy":"HARTLEYG","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C2D813-3FE8-084B-E053-F662850AB4D3","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Capillary leak syndrome","valueDescription":"Capillary leak syndrome","ValueMeaning":{"publicId":"6062431","version":"1","preferredName":"Capillary leak syndrome","longName":"6062431","preferredDefinition":"A disorder characterized by leakage of intravascular fluids into the extravascular space. This syndrome is observed in patients who demonstrate a state of generalized leaky capillaries following shock syndromes, low-flow states, ischemia-reperfusion injuries, toxemias, medications, or poisoning. It can lead to generalized edema and multiple organ failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Capillary Leak Syndrome, CTCAE","conceptCode":"C143349","definition":"A disorder characterized by leakage of intravascular fluids into the extravascular space. This syndrome is observed in patients who demonstrate a state of generalized leaky capillaries following shock syndromes, low-flow states, ischemia-reperfusion injuries, toxemias, medications, or poisoning. It can lead to generalized edema and multiple organ failure.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6491E61C-8838-0D64-E053-F662850AFD08","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-06","modifiedBy":"HARTLEYG","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C22416-ABEF-086C-E053-F662850A59CD","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Arthralgia","valueDescription":"Arthralgia","ValueMeaning":{"publicId":"6061644","version":"1","preferredName":"Arthralgia","longName":"6061644","preferredDefinition":"A disorder characterized by a sensation of marked discomfort in a joint.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arthralgia, CTCAE","conceptCode":"C143298","definition":"A disorder characterized by a sensation of marked discomfort in a joint.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64821F28-EC3B-6579-E053-F662850AF3F1","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"HARTLEYG","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C22416-ABF9-086C-E053-F662850A59CD","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Anorexia","valueDescription":"Anorexia","ValueMeaning":{"publicId":"6061665","version":"1","preferredName":"Anorexia","longName":"6061665","preferredDefinition":"A disorder characterized by a loss of appetite.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anorexia, CTCAE","conceptCode":"C57118","definition":"A disorder characterized by a loss of appetite.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64821F28-EF3D-6579-E053-F662850AF3F1","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"MAESKEB","dateModified":"2018-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C22416-AC03-086C-E053-F662850A59CD","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Acute kidney injury","valueDescription":"Acute kidney injury","ValueMeaning":{"publicId":"6061839","version":"1","preferredName":"Acute kidney injury","longName":"6061839","preferredDefinition":"A disorder characterized by the acute loss of renal function (within 2 weeks) and is traditionally classified as pre-renal (low blood flow into kidney), renal (kidney damage) and post-renal causes (ureteral or bladder outflow obstruction).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Kidney Injury, CTCAE","conceptCode":"C143262","definition":"A disorder characterized by the acute loss of renal function (within 2 weeks) and is traditionally classified as pre-renal (low blood flow into kidney), renal (kidney damage) and post-renal causes (ureteral or bladder outflow obstruction).","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"648E578C-D11D-0457-E053-F662850A29EC","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-06","modifiedBy":"HARTLEYG","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C22416-AC0D-086C-E053-F662850A59CD","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Abdominal pain","valueDescription":"Abdominal pain","ValueMeaning":{"publicId":"6063484","version":"1","preferredName":"Abdominal pain","longName":"6063484","preferredDefinition":"A disorder characterized by a sensation of marked discomfort in the abdominal region.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abdominal Pain, CTCAE","conceptCode":"C143255","definition":"A disorder characterized by a sensation of marked discomfort in the abdominal region.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64948057-0B4E-1045-E053-F662850AD8CF","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-06","modifiedBy":"HARTLEYG","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C22416-AC17-086C-E053-F662850A59CD","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Vomiting","valueDescription":"Vomiting","ValueMeaning":{"publicId":"6060492","version":"1","preferredName":"Vomiting","longName":"6060492","preferredDefinition":"A disorder characterized by the reflexive act of ejecting the contents of the stomach through the mouth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vomiting, CTCAE","conceptCode":"C57896","definition":"A disorder characterized by the reflexive act of ejecting the contents of the stomach through the mouth.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647F0736-C6C7-7710-E053-F662850A23C1","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"MAESKEB","dateModified":"2018-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C2756D-0187-793C-E053-F662850A4B19","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Thromboembolic event","valueDescription":"Thromboembolic event","ValueMeaning":{"publicId":"6063460","version":"1","preferredName":"Thromboembolic event","longName":"6063460","preferredDefinition":"A disorder characterized by occlusion of a vessel by a thrombus that has migrated from a distal site via the blood stream.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thromboembolic Event, CTCAE","conceptCode":"C143873","definition":"A disorder characterized by occlusion of a vessel by a thrombus that has migrated from a distal site via the blood stream.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64948057-0806-1045-E053-F662850AD8CF","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-06","modifiedBy":"MAESKEB","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C2756D-0191-793C-E053-F662850A4B19","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Restrictive cardiomyopathy","valueDescription":"Restrictive cardiomyopathy","ValueMeaning":{"publicId":"6060152","version":"1","preferredName":"Restrictive cardiomyopathy","longName":"6060152","preferredDefinition":"A disorder characterized by an inability of the ventricles to fill with blood because the myocardium (heart muscle) stiffens and loses its flexibility.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Restrictive Cardiomyopathy, CTCAE","conceptCode":"C55069","definition":"A disorder characterized by an inability of the ventricles to fill with blood because the myocardium (heart muscle) stiffens and loses its flexibility.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647CB354-4BD0-5B01-E053-F662850A549B","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"MAESKEB","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C2756D-019B-793C-E053-F662850A4B19","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Pericarditis","valueDescription":"Pericarditis","ValueMeaning":{"publicId":"6060154","version":"1","preferredName":"Pericarditis","longName":"6060154","preferredDefinition":"A disorder characterized by irritation to the layers of the pericardium (the protective sac around the heart).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pericarditis, CTCAE","conceptCode":"C55067","definition":"A disorder characterized by irritation to the layers of the pericardium (the protective sac around the heart).","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647CB354-4C16-5B01-E053-F662850A549B","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"MAESKEB","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C2756D-01A5-793C-E053-F662850A4B19","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Pericardial effusion","valueDescription":"Pericardial effusion","ValueMeaning":{"publicId":"6060156","version":"1","preferredName":"Pericardial effusion","longName":"6060156","preferredDefinition":"A disorder characterized by fluid collection within the pericardial sac, usually due to inflammation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pericardial Effusion, CTCAE","conceptCode":"C143743","definition":"A disorder characterized by fluid collection within the pericardial sac, usually due to inflammation.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647CB354-4C5C-5B01-E053-F662850A549B","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"MAESKEB","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C263C4-A80E-12A0-E053-F662850AE583","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Nausea","valueDescription":"Nausea","ValueMeaning":{"publicId":"6060530","version":"1","preferredName":"Nausea","longName":"6060530","preferredDefinition":"A disorder characterized by a queasy sensation and/or the urge to vomit.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nausea, CTCAE 5.0","conceptCode":"C146764","definition":"A disorder characterized by a queasy sensation and/or the urge to vomit.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647F0736-CC05-7710-E053-F662850A23C1","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"MAESKEB","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C263C4-A82C-12A0-E053-F662850AE583","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Myocardial infarction","valueDescription":"Myocardial infarction","ValueMeaning":{"publicId":"6060160","version":"1","preferredName":"Myocardial infarction","longName":"6060160","preferredDefinition":"A disorder characterized by gross necrosis of the myocardium; this is due to an interruption of blood supply to the area.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myocardial Infarction, CTCAE","conceptCode":"C143691","definition":"A disorder characterized by gross necrosis of the myocardium; this is due to an interruption of blood supply to the area.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647CB354-4CE8-5B01-E053-F662850A549B","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"MAESKEB","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C263C4-A836-12A0-E053-F662850AE583","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Myalgia","valueDescription":"Myalgia","ValueMeaning":{"publicId":"6061618","version":"1","preferredName":"Myalgia","longName":"6061618","preferredDefinition":"A disorder characterized by marked discomfort sensation originating from a muscle or group of muscles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myalgia, CTCAE","conceptCode":"C143688","definition":"A disorder characterized by marked discomfort sensation originating from a muscle or group of muscles.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64821F28-E8A9-6579-E053-F662850AF3F1","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"MAESKEB","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C263C4-A840-12A0-E053-F662850AE583","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Hypotension","valueDescription":"Hypotension","ValueMeaning":{"publicId":"6062426","version":"1","preferredName":"Hypotension","longName":"6062426","preferredDefinition":"A disorder characterized by a blood pressure that is below the normal expected for an individual in a given environment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypotension, CTCAE","conceptCode":"C55061","definition":"A disorder characterized by a blood pressure that is below the normal expected for an individual in a given environment.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6491E61C-8789-0D64-E053-F662850AFD08","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-06","modifiedBy":"MAESKEB","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C263C4-A84A-12A0-E053-F662850AE583","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Hypertension","valueDescription":"Hypertension","ValueMeaning":{"publicId":"6062427","version":"1","preferredName":"Hypertension","longName":"6062427","preferredDefinition":"A disorder characterized by a pathological increase in blood pressure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypertension, CTCAE","conceptCode":"C55060","definition":"A disorder characterized by a pathological increase in blood pressure.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6491E61C-87AC-0D64-E053-F662850AFD08","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-06","modifiedBy":"MAESKEB","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C263C4-A854-12A0-E053-F662850AE583","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Dyspepsia","valueDescription":"Dyspepsia","ValueMeaning":{"publicId":"6060227","version":"1","preferredName":"Dyspepsia","longName":"6060227","preferredDefinition":"A disorder characterized by an uncomfortable, often painful feeling in the stomach, resulting from impaired digestion. Symptoms include burning stomach, bloating, heartburn, nausea and vomiting.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dyspepsia, CTCAE","conceptCode":"C143425","definition":"A disorder characterized by an uncomfortable, often painful feeling in the stomach, resulting from impaired digestion. Symptoms include burning stomach, bloating, heartburn, nausea and vomiting.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647D160E-2708-6209-E053-F662850A6311","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"HARTLEYG","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C263C4-A85E-12A0-E053-F662850AE583","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Dysgeusia","valueDescription":"Dysgeusia","ValueMeaning":{"publicId":"6061752","version":"1","preferredName":"Dysgeusia","longName":"6061752","preferredDefinition":"A disorder characterized by abnormal sensual experience with the taste of foodstuffs; it can be related to a decrease in the sense of smell.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dysgeusia, CTCAE","conceptCode":"C143422","definition":"A disorder characterized by abnormal sensual experience with the taste of foodstuffs; it can be related to a decrease in the sense of smell.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6482A7F1-51C5-582C-E053-F662850A7D99","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"HARTLEYG","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C263C4-A868-12A0-E053-F662850AE583","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Diarrhea","valueDescription":"Diarrhea","ValueMeaning":{"publicId":"6063480","version":"1","preferredName":"Diarrhea","longName":"6063480","preferredDefinition":"A disorder characterized by an increase in frequency and/or loose or watery bowel movements.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diarrhea, CTCAE","conceptCode":"C57788","definition":"A disorder characterized by an increase in frequency and/or loose or watery bowel movements.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64948057-0AC2-1045-E053-F662850AD8CF","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-06","modifiedBy":"MAESKEB","dateModified":"2018-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C263C4-A872-12A0-E053-F662850AE583","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Constipation","valueDescription":"Constipation","ValueMeaning":{"publicId":"6060236","version":"1","preferredName":"Constipation","longName":"6060236","preferredDefinition":"A disorder characterized by irregular and infrequent or difficult evacuation of the bowels.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Constipation, CTCAE","conceptCode":"C57141","definition":"A disorder characterized by irregular and infrequent or difficult evacuation of the bowels.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647D160E-284D-6209-E053-F662850A6311","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"MAESKEB","dateModified":"2018-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C263C4-A87C-12A0-E053-F662850AE583","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Left ventricular systolic dysfunction","valueDescription":"Left ventricular systolic dysfunction","ValueMeaning":{"publicId":"6060164","version":"1","preferredName":"Left ventricular systolic dysfunction","longName":"6060164","preferredDefinition":"A disorder characterized by failure of the left ventricle to produce adequate output.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Left Ventricular Systolic Dysfunction, CTCAE 5.0","conceptCode":"C146719","definition":"A disorder characterized by failure of the left ventricle to produce adequate output.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647CB354-4D74-5B01-E053-F662850A549B","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"MAESKEB","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92C2D813-3FC0-084B-E053-F662850AB4D3","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","deletedIndicator":"No"},{"value":"Headache","valueDescription":"Headache","ValueMeaning":{"publicId":"6061743","version":"1","preferredName":"Headache","longName":"6061743","preferredDefinition":"A disorder characterized by a sensation of marked discomfort in various parts of the head, not confined to the area of distribution of any nerve.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Headache, CTCAE","conceptCode":"C143527","definition":"A disorder characterized by a sensation of marked discomfort in various parts of the head, not confined to the area of distribution of any nerve.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6482A7F1-5088-582C-E053-F662850A7D99","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"HARTLEYG","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9585B44E-56D5-77CD-E053-F662850A59B0","beginDate":"2019-10-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"Fatigue","valueDescription":"Fatigue","ValueMeaning":{"publicId":"6061416","version":"1","preferredName":"Fatigue","longName":"6061416","preferredDefinition":"A disorder characterized by a state of generalized weakness with a pronounced inability to summon sufficient energy to accomplish daily activities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fatigue, CTCAE 5.0","conceptCode":"C146753","definition":"A disorder characterized by a state of generalized weakness with a pronounced inability to summon sufficient energy to accomplish daily activities.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647F350E-B6C4-0B99-E053-F662850A61FB","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"MAESKEB","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9585B44E-56DF-77CD-E053-F662850A59B0","beginDate":"2019-10-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"Encephalopathy","valueDescription":"Encephalopathy","ValueMeaning":{"publicId":"6061749","version":"1","preferredName":"Encephalopathy","longName":"6061749","preferredDefinition":"A disorder characterized by a pathologic process involving the brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Encephalopathy, CTCAE 5.0","conceptCode":"C146699","definition":"A disorder characterized by a pathologic process involving the brain.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6482A7F1-515C-582C-E053-F662850A7D99","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"MAESKEB","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9585B44E-56E9-77CD-E053-F662850A59B0","beginDate":"2019-10-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"Dyspnea","valueDescription":"Dyspnea","ValueMeaning":{"publicId":"6062286","version":"1","preferredName":"Dyspnea","longName":"6062286","preferredDefinition":"A disorder characterized by an uncomfortable sensation of difficulty breathing.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dyspnea, CTCAE","conceptCode":"C58185","definition":"A disorder characterized by an uncomfortable sensation of difficulty breathing.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64905693-3FD9-7E3F-E053-F662850A9292","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-06","modifiedBy":"MAESKEB","dateModified":"2018-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9585B44E-56F3-77CD-E053-F662850A59B0","beginDate":"2019-10-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"Dizziness","valueDescription":"Dizziness","ValueMeaning":{"publicId":"6061755","version":"1","preferredName":"Dizziness","longName":"6061755","preferredDefinition":"A disorder characterized by a disturbing sensation of lightheadedness, unsteadiness, giddiness, spinning or rocking.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dizziness, CTCAE 5.0","conceptCode":"C146747","definition":"A disorder characterized by a disturbing sensation of lightheadedness, unsteadiness, giddiness, spinning or rocking.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6482A7F1-522E-582C-E053-F662850A7D99","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"MAESKEB","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9585B44E-56FD-77CD-E053-F662850A59B0","beginDate":"2019-10-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"Chills","valueDescription":"Chills","ValueMeaning":{"publicId":"6060491","version":"1","preferredName":"Chills","longName":"6060491","preferredDefinition":"A disorder characterized by a sensation of cold that often marks a physiologic response to sweating after a fever.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chills, CTCAE","conceptCode":"C143366","definition":"A disorder characterized by a sensation of cold that often marks a physiologic response to sweating after a fever.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647F0736-C6A4-7710-E053-F662850A23C1","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"HARTLEYG","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9585B44E-5707-77CD-E053-F662850A59B0","beginDate":"2019-10-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"Alanine aminotransferase increased (ALT)","valueDescription":"Alanine aminotransferase increased","ValueMeaning":{"publicId":"6061708","version":"1","preferredName":"Alanine aminotransferase increased","longName":"6061708","preferredDefinition":"A finding based on laboratory test results that indicate an increase in the level of alanine aminotransferase (ALT or SGPT) in the blood specimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alanine Aminotransferase Increased, CTCAE","conceptCode":"C143267","definition":"A finding based on laboratory test results that indicate an increase in the level of alanine aminotransferase (ALT or SGPT) in the blood specimen.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64821F28-F530-6579-E053-F662850AF3F1","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"HARTLEYG","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9585B44E-571B-77CD-E053-F662850A59B0","beginDate":"2019-09-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"Aspartate aminotransferase increased (AST)","valueDescription":"Aspartate aminotransferase increased","ValueMeaning":{"publicId":"6061706","version":"1","preferredName":"Aspartate aminotransferase increased","longName":"6061706","preferredDefinition":"A finding based on laboratory test results that indicate an increase in the level of aspartate aminotransferase (AST or SGOT) in a blood specimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aspartate Aminotransferase Increased, CTCAE","conceptCode":"C143301","definition":"A finding based on laboratory test results that indicate an increase in the level of aspartate aminotransferase (AST or SGOT) in a blood specimen.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64821F28-F4EA-6579-E053-F662850AF3F1","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"HARTLEYG","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95FB1E83-D0FD-5FE6-E053-F662850A34ED","beginDate":"2019-10-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-28","modifiedBy":"ONEDATA","dateModified":"2019-10-28","deletedIndicator":"No"},{"value":"Alkaline phosphatase increased","valueDescription":"Alkaline phosphatase increased","ValueMeaning":{"publicId":"6061707","version":"1","preferredName":"Alkaline phosphatase increased","longName":"6061707","preferredDefinition":"A finding based on laboratory test results that indicate an increase in the level of alkaline phosphatase in a blood specimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alkaline Phosphatase Increased, CTCAE","conceptCode":"C143269","definition":"A finding based on laboratory test results that indicate an increase in the level of alkaline phosphatase in a blood specimen.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64821F28-F50D-6579-E053-F662850AF3F1","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"HARTLEYG","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95FB1E83-D107-5FE6-E053-F662850A34ED","beginDate":"2019-10-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-28","modifiedBy":"ONEDATA","dateModified":"2019-10-28","deletedIndicator":"No"},{"value":"Muscle weakness, generalized or specific area","valueDescription":"Muscle weakness lower limb Muscle weakness trunk Muscle weakness upper limb Generalized muscle weakness","ValueMeaning":{"publicId":"6998768","version":"1","preferredName":"Muscle weakness lower limb Muscle weakness trunk Muscle weakness upper limb Generalized muscle weakness","longName":"6998768","preferredDefinition":"A disorder characterized by a reduction in the strength of the lower limb muscles.: A disorder characterized by a reduction in the strength of the trunk muscles.: A disorder characterized by a reduction in the strength of the upper limb muscles.: A disorder characterized by a reduction in the strength of muscles in multiple anatomic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Muscle Weakness Lower Limb, CTCAE","conceptCode":"C143682","definition":"A disorder characterized by a reduction in the strength of the lower limb muscles.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Muscle Weakness Trunk, CTCAE","conceptCode":"C143684","definition":"A disorder characterized by a reduction in the strength of the trunk muscles.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Muscle Weakness Upper Limb, CTCAE","conceptCode":"C143685","definition":"A disorder characterized by a reduction in the strength of the upper limb muscles.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Generalized Muscle Weakness, CTCAE","conceptCode":"C143514","definition":"A disorder characterized by a reduction in the strength of muscles in multiple anatomic sites.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95062A6A-3A91-79D2-E053-F662850A8BFD","latestVersionIndicator":"Yes","beginDate":"2019-10-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-16","modifiedBy":"ONEDATA","dateModified":"2019-10-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95062A6A-3AAA-79D2-E053-F662850A8BFD","beginDate":"2019-10-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-16","modifiedBy":"ONEDATA","dateModified":"2019-10-16","deletedIndicator":"No"},{"value":"Cardiac arrhythmia","valueDescription":"Common Terminology Criteria for Adverse Events Arrhythmia","ValueMeaning":{"publicId":"6998769","version":"1","preferredName":"Common Terminology Criteria for Adverse Events Arrhythmia","longName":"6998769","preferredDefinition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.: Any variation from the normal rate or rhythm (which may include the origin of the impulse and/or its subsequent propagation) in the heart.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common Terminology Criteria for Adverse Events","conceptCode":"C49704","definition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Arrhythmia","conceptCode":"C2881","definition":"Any variation from the normal rate or rhythm (which may include the origin of the impulse and/or its subsequent propagation) in the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95062A6A-3AB7-79D2-E053-F662850A8BFD","latestVersionIndicator":"Yes","beginDate":"2019-10-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-16","modifiedBy":"ONEDATA","dateModified":"2019-10-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95062A6A-3AD0-79D2-E053-F662850A8BFD","beginDate":"2019-10-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-16","modifiedBy":"ONEDATA","dateModified":"2019-10-16","deletedIndicator":"No"},{"value":"Gastroenteritis","valueDescription":"Common Terminology Criteria for Adverse Events Gastroenteritis","ValueMeaning":{"publicId":"6998770","version":"1","preferredName":"Common Terminology Criteria for Adverse Events Gastroenteritis","longName":"6998770","preferredDefinition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.: An inflammatory disorder that affects the upper and lower gastrointestinal tract. Most commonly, this is attributed to viruses; however bacteria, parasites or adverse reactions can also be the culprit. Symptoms include acute diarrhea and vomiting.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common Terminology Criteria for Adverse Events","conceptCode":"C49704","definition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gastroenteritis","conceptCode":"C34632","definition":"An inflammatory disorder that affects the upper and lower gastrointestinal tract. Most commonly, this is attributed to viruses; however bacteria, parasites or adverse reactions can also be the culprit. Symptoms include acute diarrhea and vomiting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95062A6A-3AF1-79D2-E053-F662850A8BFD","latestVersionIndicator":"Yes","beginDate":"2019-10-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-16","modifiedBy":"ONEDATA","dateModified":"2019-10-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95062A6A-3B0A-79D2-E053-F662850A8BFD","beginDate":"2019-10-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-16","modifiedBy":"ONEDATA","dateModified":"2019-10-16","deletedIndicator":"No"},{"value":"New or worsening heart failure","valueDescription":"New or Worsening Symptom Heart failure","ValueMeaning":{"publicId":"6998815","version":"1","preferredName":"New or Worsening Symptom Heart failure","longName":"6998815","preferredDefinition":"The subjective evidence of disease perceived by the patient that can be classified as new or worsening: A disorder characterized by the inability of the heart to pump blood at an adequate volume to meet tissue metabolic requirements, or, the ability to do so only at an elevation in the filling pressure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"New or Worsening Symptom","conceptCode":"C119238","definition":"The subjective evidence of disease perceived by the patient that can be classified as new or worsening","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Heart Failure, CTCAE","conceptCode":"C143529","definition":"A disorder characterized by the inability of the heart to pump blood at an adequate volume to meet tissue metabolic requirements, or, the ability to do so only at an elevation in the filling pressure.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95068A85-A54B-7A65-E053-F662850A305B","latestVersionIndicator":"Yes","beginDate":"2019-10-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-16","modifiedBy":"ONEDATA","dateModified":"2019-10-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95068A85-A564-7A65-E053-F662850A305B","beginDate":"2019-10-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-16","modifiedBy":"ONEDATA","dateModified":"2019-10-16","deletedIndicator":"No"},{"value":"Tremor","valueDescription":"Tremor","ValueMeaning":{"publicId":"6061867","version":"1","preferredName":"Tremor","longName":"6061867","preferredDefinition":"A disorder characterized by the uncontrolled shaking movement of the whole body or individual parts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tremor, CTCAE 5.0","conceptCode":"C146780","definition":"A disorder characterized by the uncontrolled shaking movement of the whole body or individual parts.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"648E578C-D4FF-0457-E053-F662850A29EC","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-06","modifiedBy":"MAESKEB","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9585C0E5-EF0D-3090-E053-F662850A005D","beginDate":"2019-10-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"Respiratory failure","valueDescription":"Respiratory failure","ValueMeaning":{"publicId":"6062487","version":"1","preferredName":"Respiratory failure","longName":"6062487","preferredDefinition":"A disorder characterized by impaired gas exchange by the respiratory system resulting in hypoxia and a decrease in oxygenation of the tissues that may be associated with an increase in arterial levels of carbon dioxide.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Respiratory Failure, CTCAE","conceptCode":"C143809","definition":"A disorder characterized by impaired gas exchange by the respiratory system resulting in hypoxia and a decrease in oxygenation of the tissues that may be associated with an increase in arterial levels of carbon dioxide.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6491E61C-8FFA-0D64-E053-F662850AFD08","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-06","modifiedBy":"MAESKEB","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9585C0E5-EF17-3090-E053-F662850A005D","beginDate":"2019-10-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"Pulmonary edema","valueDescription":"Pulmonary edema","ValueMeaning":{"publicId":"6062491","version":"1","preferredName":"Pulmonary edema","longName":"6062491","preferredDefinition":"A disorder characterized by accumulation of fluid in the lung tissues that causes a disturbance of the gas exchange that may lead to respiratory failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary Edema, CTCAE","conceptCode":"C143789","definition":"A disorder characterized by accumulation of fluid in the lung tissues that causes a disturbance of the gas exchange that may lead to respiratory failure.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6491E61C-9086-0D64-E053-F662850AFD08","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-06","modifiedBy":"HARTLEYG","dateModified":"2018-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9585C0E5-EF21-3090-E053-F662850A005D","beginDate":"2019-10-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"Productive cough","valueDescription":"Productive cough","ValueMeaning":{"publicId":"6062492","version":"1","preferredName":"Productive cough","longName":"6062492","preferredDefinition":"A disorder characterized by expectorated secretions upon coughing.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Productive Cough, CTCAE","conceptCode":"C143780","definition":"A disorder characterized by expectorated secretions upon coughing.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6491E61C-90A9-0D64-E053-F662850AFD08","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-06","modifiedBy":"MAESKEB","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9585C0E5-EF2B-3090-E053-F662850A005D","beginDate":"2019-10-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"Intestinal obstruction (includes small intestine and colonic)","valueDescription":"Colonic obstruction And/Or Small intestinal obstruction Bowel Obstruction","ValueMeaning":{"publicId":"7029327","version":"1","preferredName":"Colonic obstruction And/Or Small intestinal obstruction Bowel Obstruction","longName":"7029327","preferredDefinition":"A disorder characterized by blockage of the normal flow of the intestinal contents in the colon.: Used to indicate that either or both of two items or options may be valid.: A disorder characterized by blockage of the normal flow of the intestinal contents of the small intestine.: Blockage of the normal flow of the intestinal contents within the bowel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colonic Obstruction, CTCAE","conceptCode":"C143375","definition":"A disorder characterized by blockage of the normal flow of the intestinal contents in the colon.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Small Intestinal Obstruction, CTCAE","conceptCode":"C143843","definition":"A disorder characterized by blockage of the normal flow of the intestinal contents of the small intestine.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Bowel Obstruction","conceptCode":"C9175","definition":"Blockage of the normal flow of the intestinal contents within the bowel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95FB7588-A185-5C61-E053-F662850A3384","latestVersionIndicator":"Yes","beginDate":"2019-10-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-28","modifiedBy":"ONEDATA","dateModified":"2019-10-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95FB7588-A19E-5C61-E053-F662850A3384","beginDate":"2019-10-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-28","modifiedBy":"ONEDATA","dateModified":"2019-10-28","deletedIndicator":"No"},{"value":"Acute respiratory distress syndrome","valueDescription":"Adult respiratory distress syndrome","ValueMeaning":{"publicId":"6062298","version":"1","preferredName":"Adult respiratory distress syndrome","longName":"6062298","preferredDefinition":"A disorder characterized by progressive and life-threatening pulmonary distress in the absence of an underlying pulmonary condition, usually following major trauma or surgery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adult Respiratory Distress Syndrome, CTCAE","conceptCode":"C58020","definition":"A disorder characterized by progressive and life-threatening pulmonary distress in the absence of an underlying pulmonary condition, usually following major trauma or surgery.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64905693-4187-7E3F-E053-F662850A9292","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-06","modifiedBy":"MAESKEB","dateModified":"2018-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95FAEA74-1904-6051-E053-F662850ACA63","beginDate":"2019-10-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-28","modifiedBy":"ONEDATA","dateModified":"2019-10-28","deletedIndicator":"No"},{"value":"Edema limbs","valueDescription":"Edema limbs","ValueMeaning":{"publicId":"6061419","version":"1","preferredName":"Edema limbs","longName":"6061419","preferredDefinition":"A disorder characterized by swelling due to excessive fluid accumulation in the upper or lower extremities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Edema Limbs, CTCAE","conceptCode":"C143433","definition":"A disorder characterized by swelling due to excessive fluid accumulation in the upper or lower extremities.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647F350E-B72D-0B99-E053-F662850A61FB","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"HARTLEYG","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95FB7588-A1A8-5C61-E053-F662850A3384","beginDate":"2019-10-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-28","modifiedBy":"ONEDATA","dateModified":"2019-10-28","deletedIndicator":"No"},{"value":"Mucositis oral","valueDescription":"Mucositis oral","ValueMeaning":{"publicId":"6060531","version":"1","preferredName":"Mucositis oral","longName":"6060531","preferredDefinition":"A disorder characterized by ulceration or inflammation of the oral mucosal.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucositis Oral, CTCAE","conceptCode":"C143679","definition":"A disorder characterized by ulceration or inflammation of the oral mucosal.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647F0736-CC28-7710-E053-F662850A23C1","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"MAESKEB","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95FB7588-A1B2-5C61-E053-F662850A3384","beginDate":"2019-10-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-28","modifiedBy":"ONEDATA","dateModified":"2019-10-28","deletedIndicator":"No"},{"value":"Hepatic failure","valueDescription":"Hepatic failure","ValueMeaning":{"publicId":"6061493","version":"1","preferredName":"Hepatic failure","longName":"6061493","preferredDefinition":"A disorder characterized by the inability of the liver to metabolize chemicals in the body. Laboratory test results reveal abnormal plasma levels of ammonia, bilirubin, lactic dehydrogenase, alkaline phosphatase, aminotransferase, and/or prolongation of prothrombin time (INR.) Drug-induced liever injury (DILI) as defined by Hy's Law.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatic Failure, CTCAE","conceptCode":"C143539","definition":"A disorder characterized by the inability of the liver to metabolize chemicals in the body. Laboratory test results reveal abnormal plasma levels of ammonia, bilirubin, lactic dehydrogenase, alkaline phosphatase, aminotransferase, and/or prolongation of prothrombin time (INR.) Drug-induced liever injury (DILI) as defined by Hy's Law.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647F72DE-E671-0439-E053-F662850A9369","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"HARTLEYG","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95FB7588-A1BC-5C61-E053-F662850A3384","beginDate":"2019-10-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-28","modifiedBy":"ONEDATA","dateModified":"2019-10-28","deletedIndicator":"No"},{"value":"Blood bilirubin increased","valueDescription":"Blood bilirubin increased","ValueMeaning":{"publicId":"6061703","version":"1","preferredName":"Blood bilirubin increased","longName":"6061703","preferredDefinition":"A finding based on laboratory test results that indicate an abnormally high level of bilirubin in the blood. Excess bilirubin is associated with jaundice.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Blood Bilirubin Increased, CTCAE","conceptCode":"C143325","definition":"A finding based on laboratory test results that indicate an abnormally high level of bilirubin in the blood. Excess bilirubin is associated with jaundice.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64821F28-F47F-6579-E053-F662850AF3F1","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"HARTLEYG","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95FB7588-A1C6-5C61-E053-F662850A3384","beginDate":"2019-10-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-28","modifiedBy":"ONEDATA","dateModified":"2019-10-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6941742","version":"1","preferredName":"Common Terminology Criteria for Adverse Events Toxicity Type","preferredDefinition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.:The finding of bodily harm due to the poisonous effects of something.:Something distinguishable as an identifiable class based on common qualities.","longName":"C49704:C27990:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common Terminology Criteria for Adverse Events","conceptCode":"C49704","definition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"92C22416-ABC8-086C-E053-F662850A59CD","latestVersionIndicator":"Yes","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"92C22416-ABD9-086C-E053-F662850A59CD","latestVersionIndicator":"Yes","beginDate":"2019-09-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-17","modifiedBy":"KUMMEROA","dateModified":"2020-02-03","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CPST_GRFT_gd4_org_toxic_type","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the organ standard t","type":"Preferred Question Text","description":"What was the organ standard toxicity grade 4 toxicity that occurred?","url":null,"context":"NHLBI"},{"name":"Specify the toxicity","type":"Alternate Question Text","description":"Specify the toxicity","url":null,"context":"NHLBI"},{"name":"Specify the toxicity","type":"Application Standard Question Text","description":"Specify the toxicity","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9271166D-97B0-3385-E053-F662850A24AF","latestVersionIndicator":"Yes","beginDate":"2019-09-13","endDate":null,"createdBy":"MALUMK","dateCreated":"2019-09-13","modifiedBy":"KUMMEROA","dateModified":"2020-02-03","changeDescription":". System generated def displayed as alt def.; System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}